UK industry condemns specials "drug pricing racket"
This article was originally published in Scrip
Some pharmaceutical companies in the UK and pharmacists have been fixing the prices of so-called "specials", unlicensed drugs prescribed for patients who have no licensed options, according to an undercover sting by the Daily Telegraph. Both the Association of Pharmaceutical Specials Manufacturers, which represents the companies that make these medicines, and the Association of the British Pharmaceutical Industry have condemned the "alleged" activities.
You may also be interested in...
Financial ties between companies and healthcare bodies distort the production and use of evidence, claims a paper co-authored by researchers, clinicians and decision makers, including a representative of Germany’s HTA body, IQWiG.
Meindert Boysen, head of NICE’s Centre For Health Technology Evaluation, shares advice for companies aiming to get their medicine to patients. His golden rules: engage in early advice and be more realistic about pricing.